| 发明名称 |
Oligonucleotides for use in prophylaxis and/or treatment of TGF-beta1 and TGF-beta2, TGF-beta2 and TGF-beta3, TGF-beta1 and TGF-beta3, or TGF-beta1, TGF-beta2, and TGF-beta3 mRNA overexpressing diseases |
| 摘要 |
<p>The present invention refers to an oligonucleotide for use in prophylaxis and/or treatment of a TGF-beta1 and TGF-beta 2 mRNA overexpressing tumor, a TGF-beta2 and TGF-beta3 mRNA overexpressing tumor, a TGF-beta1 and TGF-beta3 mRNA overexpressing tumor, or a TGF-beta1, TGF-beta 2, and TGF-beta3 mRNA overexpressing tumor.</p> |
| 申请公布号 |
EP2453017(A9) |
申请公布日期 |
2012.12.26 |
| 申请号 |
EP20100191103 |
申请日期 |
2010.11.12 |
| 申请人 |
ANTISENSE PHARMA GMBH |
发明人 |
JASCHINSKI, FRANK;ROTHAMMER-HAMPL, TANJA;SCHNEIDER, ANNELIESE;SCHLINGENSIEPEN, KARL-HERMANN |
| 分类号 |
C12N15/113;A61K31/7088;A61P35/00 |
主分类号 |
C12N15/113 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
